{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:20:34Z","timestamp":1788322834799,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective of the study was to describe the frequencies of health-care utilization by people with substance use disorder (SUD), including contacts with general practitioners (GP), psychiatrists, emergency departments (ED) and hospital admissions and to compare this frequency to the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the national register of people who were in treatment for SUD between 2011 and 2014 was linked to health care data from the Belgian health insurance (N\u2009=\u200930,905). Four comparators were matched on age, sex and place of residence to each subject in treatment for SUD (N\u2009=\u2009123,620). Cases were further divided in five mutually exclusive categories based on the main SUD (opiates, crack\/cocaine, stimulants, cannabis and alcohol). We calculated the average number of contacts with GP, psychiatrists and ED, and hospital admissions per person over a ten year period (2008\u20132017), computed descriptive statistics for each of the SUD and used negative binomial regression models to compare cases and comparators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the ten-year period, people in treatment for SUD overall had on average 60 GP contacts, 3.9 psychiatrist contacts, 7.8 visits to the ED, and 16 hospital admissions. Rate ratios, comparing cases and corresponding comparators, showed that people in treatment for SUD had on average 1.9 more contacts with a GP (95\u2009% CI 1.9-2.0), 7.4 more contacts with a psychiatrist (95\u2009% CI 7.0-7.7), 4.2 more ED visits (95\u2009% CI 4.2\u20134.3), and 6.4 more hospital admissions (95\u2009% CI 6.3\u20136.5).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of health services for people with SUD is between almost two (GP) and seven times (psychiatrist) higher than for comparators. People in treatment for alcohol use disorders use health care services more frequently than people in treatment for other SUD. The use of health services remained stable in the five years before and after the moment people with SUD entered into treatment for SUD. The higher use of primary health care services by people with SUD might indicate that they have higher health care needs than comparators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-021-00620-5","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:06:34Z","timestamp":1624424794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of health care services by people with substance use disorders in Belgium: a register-based cohort study"],"prefix":"10.1186","volume":"79","author":[{"given":"Luk","family":"Van Baelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Plettinckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brecht","family":"Devleesschauwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Gremeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/14659891.2019.1604841","volume":"24","author":"L Van Baelen","year":"2019","unstructured":"Van Baelen L, Antoine J, De Ridder K, et al. All-cause mortality rate of people in treatment for substance use disorders in Belgium: A register-based cohort study. Journal of Substance Use. 2019;24:481\u20136. https:\/\/doi.org\/10.1080\/14659891.2019.1604841.","journal-title":"Journal of Substance Use"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(18)32225-6.","journal-title":"Lancet"},{"key":"620_CR3","unstructured":"Degenhardt L, Larney S, Randall D, et al. Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction. 2004. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/add.12337."},{"key":"620_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32\u201351. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03140.x.","journal-title":"Addiction"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00586-012-2334-8","volume":"22 Suppl 4","author":"J-P Millet","year":"2013","unstructured":"Millet J-P, Moreno A, Fina L, et al. Factors that influence current tuberculosis epidemiology. Eur Spine J. 2013;22 Suppl 4:539\u201348. https:\/\/doi.org\/10.1007\/s00586-012-2334-8.","journal-title":"Eur Spine J"},{"key":"620_CR6","first-page":"35","volume":"82","author":"L Van Baelen","year":"2019","unstructured":"Van Baelen L, Antoine J, De Ridder K, et al. Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study. Acta Gastroenterol Belg. 2019;82:35\u201342.","journal-title":"Acta Gastroenterol Belg"},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/QCO.0000000000000125","volume":"28","author":"A Kamarulzaman","year":"2015","unstructured":"Kamarulzaman A, Altice FL. Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis. 2015;28:10\u20136. https:\/\/doi.org\/10.1097\/QCO.0000000000000125.","journal-title":"Curr Opin Infect Dis"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.bdj.4801206","volume":"191","author":"J Sheridan","year":"2001","unstructured":"Sheridan J, Aggleton M, Carson T. Dental health and access to dental treatment: a comparison of drug users and non-drug users attending community pharmacies. Br Dent J. 2001;191:453\u20137. https:\/\/doi.org\/10.1038\/sj.bdj.4801206.","journal-title":"Br Dent J"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EPM, van Weeghel J, et al. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug Alcohol Depend. 2013;131:23\u201335.","journal-title":"Drug Alcohol Depend"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1360-0443.2007.01842.x","volume":"102","author":"E Digiusto","year":"2007","unstructured":"Digiusto E, Treloar C. Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction. 2007;102:958\u201369. https:\/\/doi.org\/10.1111\/j.1360-0443.2007.01842.x.","journal-title":"Addiction"},{"key":"620_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archpsyc.59.1.77","volume":"59","author":"R Mojtabai","year":"2002","unstructured":"Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry. 2002;59:77\u201384. https:\/\/doi.org\/10.1001\/archpsyc.59.1.77.","journal-title":"Arch Gen Psychiatry"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1360-0443.1997.tb02853.x","volume":"92","author":"A Morrisson","year":"2006","unstructured":"Morrisson A, Elliott L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 2006;92:1349\u201352. https:\/\/doi.org\/10.1111\/j.1360-0443.1997.tb02853.x.","journal-title":"Addiction"},{"key":"620_CR13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1360-0443.2008.02214.x","volume":"103","author":"GR Foster","year":"2008","unstructured":"Foster GR. Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy? Addiction. 2008;103:1412\u20133.","journal-title":"Addiction"},{"key":"620_CR14","first-page":"513","volume":"11","author":"P Higgs","year":"2011","unstructured":"Higgs P, Sacks-Davis R, Gold J, et al. Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence. Hepatitis Monthly. 2011;11:513\u20138.","journal-title":"Hepatitis Monthly"},{"key":"620_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/hep.24656","volume":"55","author":"NK Martin","year":"2012","unstructured":"Martin NK, Vickerman P, Miners A, et al. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology. 2012;55:49\u201357.","journal-title":"Hepatology"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2017.04.003","volume":"177","author":"R Bielen","year":"2017","unstructured":"Bielen R, Moreno C, Van Vlierberghe H, et al. Belgian experience with direct acting antivirals in people who inject drugs. Drug Alcohol Depend. 2017;177:214\u201320.","journal-title":"Drug Alcohol Depend"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40121-017-0158-x","volume":"6","author":"G Robaeys","year":"2017","unstructured":"Robaeys G, Christensen S, Lucidarme D, et al. Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. Infectious Diseases Therapy. 2017;6:265\u201375.","journal-title":"Infectious Diseases Therapy"},{"key":"620_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","volume":"16","author":"J Neale","year":"2008","unstructured":"Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008;16:147\u201354. https:\/\/doi.org\/10.1111\/j.1365-2524.2007.00739.x.","journal-title":"Health Soc Care Community"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2020.02.008","volume":"112S","author":"KA Stephens","year":"2020","unstructured":"Stephens KA, West II, Hallgren KA, et al. Service utilization and chronic condition outcomes among primary care patients with substance use disorders and co-occurring chronic conditions. J Subst Abuse Treat. 2020;112S:49\u201355. https:\/\/doi.org\/10.1016\/j.jsat.2020.02.008.","journal-title":"J Subst Abuse Treat"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","volume":"16","author":"S Chan Carusone","year":"2019","unstructured":"Chan Carusone S, Guta A, Robinson S, et al. \u201cMaybe if I stop the drugs, then maybe they\u2019d care?\u201d\u2014hospital care experiences of people who use drugs. Harm Reduction Journal. 2019;16:16. https:\/\/doi.org\/10.1186\/s12954-019-0285-7.","journal-title":"Harm Reduction Journal"},{"key":"620_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12904-016-0168-6","volume":"15","author":"BF Hudson","year":"2016","unstructured":"Hudson BF, Flemming K, Shulman C, et al. Challenges to access and provision of palliative care for people who are homeless: a systematic review of qualitative research. BMC Palliative Care. 2016;15:96. https:\/\/doi.org\/10.1186\/s12904-016-0168-6.","journal-title":"BMC Palliative Care"},{"key":"620_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6874-14-5","volume":"14","author":"A Olsen","year":"2014","unstructured":"Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. BMC Women\u2019s Health. 2014;14:5. https:\/\/doi.org\/10.1186\/1472-6874-14-5.","journal-title":"BMC Women\u2019s Health"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/08897077.2017.1356789","volume":"39","author":"AL Bahorik","year":"2018","unstructured":"Bahorik AL, Satre DD, Kline-Simon AH, et al. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2018;39:59\u201368. https:\/\/doi.org\/10.1080\/08897077.2017.1356789.","journal-title":"Subst Abus"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.drugalcdep.2014.01.025","volume":"138","author":"PM Sanjuan","year":"2014","unstructured":"Sanjuan PM, Rice SL, Witkiewitz K, et al. Alcohol, tobacco, and drug use among emergency department patients. Drug Alcohol Depend. 2014;138:32\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.01.025.","journal-title":"Drug Alcohol Depend"},{"key":"620_CR25","doi-asserted-by":"publisher","unstructured":"Lewer D, Freer J, King E, et al. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction. Published Online First: 9 November. 2019. https:\/\/doi.org\/10.1111\/add.14892.","DOI":"10.1111\/add.14892"},{"key":"620_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13690-016-0139-7","volume":"74","author":"J Antoine","year":"2016","unstructured":"Antoine J, De Ridder K, Plettinckx E, et al. Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol. Archives of Public Health. 2016;74:27.","journal-title":"Archives of Public Health"},{"key":"620_CR27","unstructured":"IMA. IMA Population Database. Published Online First. 4 October 2017._http:\/\/www.aim-ima.be\/Data-Populatie-53_(Accessed 17 Jun 2020)."},{"key":"620_CR28","doi-asserted-by":"publisher","unstructured":"Van Baelen L, De Ridder K, Antoine J, et al. Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage. Arch Public Health 2018;76. https:\/\/doi.org\/10.1186\/s13690-017-0249-x.","DOI":"10.1186\/s13690-017-0249-x"},{"key":"620_CR29","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLoS Medicine. 2007;4:e297.","journal-title":"PLoS Medicine"},{"key":"620_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1475-6773.2004.00244.x","volume":"39","author":"GA Zarkin","year":"2004","unstructured":"Zarkin GA, Bray JW, Babor TF, et al. Alcohol Drinking Patterns and Health Care Utilization in a Managed Care Organization. Health Serv Res. 2004;39:553\u201370. https:\/\/doi.org\/10.1111\/j.1475-6773.2004.00244.x.","journal-title":"Health Serv Res"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ADT.0000000000000069","volume":"14","author":"S Darke","year":"2015","unstructured":"Darke S, Marel C, Ross J, et al. Health Service Utilization Among Heroin Users: 11-Year Follow-up of the Australian Treatment Outcome Study Cohort. Addictive Disorders Their Treatment. 2015;14:159\u201366. https:\/\/doi.org\/10.1097\/ADT.0000000000000069.","journal-title":"Addictive Disorders Their Treatment"},{"key":"620_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/dar.12266","volume":"35","author":"N Lintzeris","year":"2016","unstructured":"Lintzeris N, Rivas C, Monds LA, et al. Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services. Drug Alcohol Rev. 2016;35:223\u201331. https:\/\/doi.org\/10.1111\/dar.12266.","journal-title":"Drug Alcohol Rev"},{"key":"620_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2014.12.009","volume":"53","author":"IN Onyeka","year":"2015","unstructured":"Onyeka IN, Beynon CM, Ronkainen K, et al. Hospitalization in a Cohort Seeking Treatment for Illicit Drug Use in Finland. J Subst Abuse Treat. 2015;53:64\u201370.","journal-title":"J Subst Abuse Treat"},{"key":"620_CR34","unstructured":"Antoine J, Renard F. Registration of treatment demands for substance use disorders in Belgium: Why are some clients registered anonymously? Lisbon: 2017. https:\/\/workspaces.wiv-isp.be\/tdi\/Documenten%20voor%20TDIRegistratie\/Use%20of%20NISS%20poster.pdf. Accesed 9 Jun 2021."}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-021-00620-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:08:59Z","timestamp":1624424939000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-021-00620-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s13690-021-00620-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42206\/v1","asserted-by":"object"}]},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"8 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Belgian Privacy Commission (SCSZG\/15\/033). IMA adheres to the Program Law of 24\/12\/2002, articles 278\u2013281. The Belgian TDI protocol adheres to the European protocol and the Belgian privacy legislation, as described by Antoine et al. [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}